Safety and immunogenicity of H5N1 vaccine.
Authier
F J
FJ
Gherardi
R K
RK
D000276:Adjuvants, Immunologic / Q000009:adverse effects* / Q000494:pharmacology; D000536:Aluminum Hydroxide / Q000009:adverse effects* / Q000494:pharmacology; D002626:Chemistry, Pharmaceutical; D005156:Facial Neuralgia / Q000139:chemically induced*; D006801:Humans; D053124:Influenza A Virus, H5N1 Subtype; D007252:Influenza Vaccines
D000276:Adjuvants, Immunologic; D007252:Influenza Vaccines; D000536:Aluminum Hydroxide